These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25692246)

  • 1. Trimethoprim-sulfamethoxazole (cotrimoxazole) desensitization in an HIV-infected 5-yr-old girl.
    Gómez-Traseira C; Boyano-Martínez T; Escosa-García L; Pedrosa M; Martín-Muñoz F; Quirce S
    Pediatr Allergy Immunol; 2015 May; 26(3):287-289. PubMed ID: 25692246
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children.
    Palusci VJ; Kaul A; Lawrence RM; Haines KA; Kwittken PL
    Pediatr Infect Dis J; 1996 May; 15(5):456-60. PubMed ID: 8724071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethoprim-sulfamethoxazole oral desensitization in hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reactions.
    Kletzel M; Beck S; Elser J; Shock N; Burks W
    Am J Dis Child; 1991 Dec; 145(12):1428-9. PubMed ID: 1688295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Treating through" hypersensitivity to cotrimoxazole in children with HIV infection.
    Kreuz W; Güngör T; Lotz C; Funk M; Kornhuber B
    Lancet; 1990 Aug; 336(8713):508-9. PubMed ID: 1975015
    [No Abstract]   [Full Text] [Related]  

  • 5. Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole.
    Lin D; Li WK; Rieder MJ
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005646. PubMed ID: 17443608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of desensitization to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients.
    Piketty C; Gilquin J; Kazatchkine MD
    J Infect Dis; 1995 Aug; 172(2):611. PubMed ID: 7622921
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful desensitization in a child with delayed cotrimoxazole hypersensitivity: A case report.
    D'Amelio CM; Del Pozo JL; Vega O; Madamba R; Gastaminza G
    Pediatr Allergy Immunol; 2016 May; 27(3):320-1. PubMed ID: 26660294
    [No Abstract]   [Full Text] [Related]  

  • 8. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus.
    Marsh BJ
    Clin Infect Dis; 1997 Sep; 25(3):754-6. PubMed ID: 9314486
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful desensitization to dapsone for Pneumocystis carinii prophylaxis in an HIV-positive patient.
    Cook DE; Kossey JL
    Ann Pharmacother; 1998 Dec; 32(12):1302-5. PubMed ID: 9876811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A severe systemic reaction to trimethoprim-sulfamethoxazole in a patient infected with the human immunodeficiency virus.
    Martin GJ; Paparello SF; Decker CF
    Clin Infect Dis; 1993 Jan; 16(1):175-6. PubMed ID: 8448303
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients.
    Carr A; Penny R; Cooper DA
    AIDS; 1993 Jan; 7(1):65-71. PubMed ID: 8442919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients.
    Absar N; Daneshvar H; Beall G
    J Allergy Clin Immunol; 1994 Jun; 93(6):1001-5. PubMed ID: 8006304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Desensitization to cotrimoxazole, rifampicin and penicillin G in nine patients with prior hypersensitivity].
    Pujal Herranz M; Roca Massa M; Domínguez Tordera P; Codina Jané C; Ribas Sala J
    Farm Hosp; 2006; 30(4):254-9. PubMed ID: 17022720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Hypersensitivity to Trimethoprim-Sulfamethoxazole With an Ultrarapid Desensitization Protocol in HIV Infection.
    Villarreal-González RV; González-Díaz SN; Canel Paredes A; De Lira-Quezada CE; Rocha-Silva GK; López Méndez A
    J Investig Allergol Clin Immunol; 2021 Feb; 32(1):66-68. PubMed ID: 34014167
    [No Abstract]   [Full Text] [Related]  

  • 15. Trimethoprim-sulphamethoxazole oral desensitization in hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reactions.
    Dis Markers; 1991; 9(6):355. PubMed ID: 1823331
    [No Abstract]   [Full Text] [Related]  

  • 16. Glutathione in hypersensitivity to trimethoprim/sulfamethoxazole in patients with HIV infection.
    Rose EW; McCloskey WW
    Ann Pharmacother; 1998 Mar; 32(3):381-3. PubMed ID: 9533069
    [No Abstract]   [Full Text] [Related]  

  • 17. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus.
    Caumes E; Guermonprez G; Winter C; Katlama C; Bricaire F
    Clin Infect Dis; 1996 Dec; 23(6):1313-4. PubMed ID: 8953079
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerance induction to cotrimoxazole.
    Nucera E; Schiavino D; Buonomo A; Del Ninno M; Sun JY; Patriarca G
    Allergy; 2000 Jul; 55(7):681-2. PubMed ID: 10921475
    [No Abstract]   [Full Text] [Related]  

  • 19. Two-day oral desensitization to trimethoprim-sulfamethoxazole in HIV-infected patients.
    Nguyen MT; Weiss PJ; Wallace MR
    AIDS; 1995 Jun; 9(6):573-5. PubMed ID: 7662195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
    Fisher RG; Nageswaran S; Valentine ME; McKinney RE
    AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.